Professor Rostaing received his MD and graduated in Nephrology from Toulouse University Medical School (France) in 1988. In 1989 he graduated in Immunology at Aix-Marseille University Medical School (France). During this period Professor Rostaing completed two overseas fellowships, one at the Collaborative Transplant Study in Heidelberg, Germany and one at the UK Transplant Services in Bristol.In 1990 he returned to Toulouse University Hospital, first as Assistant Physician in Clinical Hematology and later as Assistant Physician in Nephrology, Dialysis and Transplantation. From 1994 to 1998 he worked as a Consultant in the Organ Transplant Service at the Toulouse Hospital, and became Professor of Nephrology in 1999. He obtained his PhD from Toulouse University in 2000. From 2008 to 2015 he was the medical director of the Organ transplant program of Toulouse University Hospital. Since 2016, he moved to the department of Nephrology and Kidney Transplantation at Grenoble University Hospital (France).Professor Rostaing’s main fields of clinical and basic research include the desensitization for ABO incompatible and HLA incompatible kidney transplant, viral infections in dialysis and in organ transplant patients, particularly hepatitis C virus infection in dialysis and transplant patients; cytomegalovirus infection and disease after kidney and liver transplants; hepatitis E after organ transplantation; anemia after kidney transplantation and after liver transplantation; the pharmacodynamic effects of immunosuppressants; and the assessment of intracytoplasmic cytokines by means of flow cytometry and its relevance to alloreactivity in kidney transplant recipients and to biocompatibility in hemodialysis patients. He has authored or co-authored more than 480 papers.Professor Rostaing is a member of several professional and scientific organizations including the French Society of Nephrology, the International Society of Nephrology, the European Society of Nephrology, Dialysis, and Transplantation, the European Society of Transplantation, the European Society of Artificial Organs, the American Society of Nephrology, the International Society for Apheresis, and the American Society of Transplantation.
30 MARCH 2023
Time |
Session |
|
08:30
10:30
|
-
Frailty in Transplantation: Is Age Just a Number?
-
HLA-incompatible Kidney Transplantation
-
ABO-incompatible KT: Is it an Effective and Cost-saving Strategy in Low to Middle-Income Countries?
-
Q and A
MR 109 ABFE
|